United States· US:50090-1920_20c63fa7-fa12-4d09-a909-12c66ca07ef0
Latanoprost
A latanoprost product containing latanoprost, registered in United States by A-S Medication Solutions. The same ATC class is registered in 18 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Latanoprost is registered in 18 of 19 countries.
Countries holding a registration under ATC S01EE01 (latanoprost), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 10 of them publish a price we can compare per daily dose
Latanoprost · ATC S01EE01
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- LATANOPROST
- Manufacturer
- A-S Medication Solutions
- Country
- United States (US)
- ATC code
- S01EE01
- ATC class
- Latanoprost
- Defined daily dose
- 0.1 ml, AT
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1150090192001 BOTTLE in 1 CARTON (50090-1920-0) / 2.5 mL in 1 BOTTLE
- ndc1150090-1920-0
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
173 interactions on record for latanoprost.
Graded by severity as the source publishes them — 173 info. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Latanoprost · interactions on record
173 records
Same medicine, other countries
Latanoprost in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAKISTANPharmaselect International Beteiligungs GmbH, Vídeň
- SwedenAkistan 50 mikrogram/ml Ögondroppar, lösningPharmaselect International Beteiligungs GmbH
- BelgiumCatiolanze 50 µg/mlSanten
- FinlandCatiolanzeSanten Oy
- NetherlandsCatiolanze, 50 microgram/ml oogdruppels, emulsieSanten Oy
- PolandAkistanPharmaselect International Beteiligungs GmbH
- SwitzerlandLatano-Vision SDU
- IrelandCatiolanze 50 micrograms/mL eye drops, emulsionSanten OY
Authorised across Europe · EMA
The same active substance is authorised in 31 EEA countries. Names it is sold under:
- Austria · Akistan, Latacris
- Belgium · Latanea, Latanoprost Eg
- Bulgaria · Akistan, Ксалатан
- Cyprus · Gisolom, Latanoprost Demo
- Czechia · Akistan, Latanoprost Olikla
- Germany · Akistan, Latanelb
- Denmark · Latanoprost Genetic, Latanoprost Rivopharm
- Estonia · Glaumax, Latanoprost Actavis
- Spain · Latanest, Latanoprost Aurovitas
- Finland · Latanoprost Sandoz, Latanoprost Stada
- France · Latanoprost Bgr, Latanoprost Biogaran
- United Kingdom (Northern Ireland) · Latanoprost, Latanoprost Accord
- Greece · Latandrops, Lataneau
- Croatia · Lapovis, Latanox
- Hungary · Akistan, Laprosep
- Ireland · Latanoprost Genetic, Loravis
- Iceland · Catiolanze, Latanoprost Actavis
- Italy · Droplatan, Galaxia
- Liechtenstein · Catiolanze
- Lithuania · Latanoprost Actavis, Latanoprost Elvim
- Luxembourg · Latanea, Latanoprost Eg
- Latvia · Latanoprost Actavis, Latanoprost Elvim
- Malta · Latanoprost Genetic, Lunaris
- Netherlands · Latanea, Latanmono Conserveermiddelvrij
- Norway · Catiolanze, Ditiamgo
- Poland · Akistan, Latanoprost Genoptim
- Portugal · Enicil, Enicilfree
- Romania · Akistan, Glautan
- Sweden · Latanoprost Actavis, Latanoprost Genetic
- Slovenia · Akistan, Latanoprost Genetic
- Slovakia · Akistan, Latanoprost Olikla
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e078330c-dd10-439a-9767-b0e4f853df8d GET /v1/drugs/e078330c-dd10-439a-9767-b0e4f853df8d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "OPHTHALMIC",
"source": "ndc",
"strength": "50",
"substance": "LATANOPROST",
"productndc": "50090-1920",
"dosage_form": "SOLUTION/ DROPS",
"dea_schedule": null,
"strength_unit": "ug/mL",
"application_number": "ANDA201006",
"marketing_category": "ANDA"
}See everything about latanoprost.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.